Paxman Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 151

Employees

  • Stock Symbol
  • PAX

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $6.73
  • (As of Friday Closing)

Paxman General Information

Description

Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.

Contact Information

Website
investor.paxmangroup.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Pirgatan 13
  • 374 35 Karlshamn
  • Sweden
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Therapeutic Devices
Stock Exchange
STO
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • Pirgatan 13
  • 374 35 Karlshamn
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Paxman Stock Performance

As of 13-Nov-2026, Paxman’s stock price is $6.73. Its current market cap is $157M with 23.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.73 $6.27 $4.48 - $7.10 $157M 23.3M 26.8K -$0.02

Paxman Financials Summary

As of 30-Jun-2026, Paxman has a trailing 12-month revenue of $39.1M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 107,634 129,455 111,629 69,456
Revenue 39,075 31,894 23,923 19,768
EBITDA 4,053 2,897 4,702 2,938
Net Income (539) (1,701) 3,801 784
Total Assets 50,243 52,066 20,595 16,723
Total Debt 1,273 1,413 1,295 1,358
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Paxman Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Paxman‘s full profile, request access.

Request a free trial

Paxman Patents

  • 89

    Total Documents Applications and Grants

  • Total Patents Families

  • 58

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Paxman Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4812134-A1 Scalp cooling cap Pending 07-Jan-2024
GB-202400207-D0 Scalp cooling cap Inactive 07-Jan-2024
WO-2025146554-A1 Scalp cooling cap Inactive 07-Jan-2024
EP-4812135-A1 Scalp cooling cap cover Pending 07-Jan-2024
GB-202400211-D0 Scalp cooling cap cover Inactive 07-Jan-2024 A61F7/00
To view Paxman’s complete patent history, request access »

Paxman Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Paxman Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Paxman‘s full profile, request access.

Request a free trial

Paxman Acquisitions (1)

Paxman’s most recent deal was a Merger/Acquisition with Dignitana for . The deal was made on 08-May-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dignitana 08-May-2025 Merger/Acquisition Therapeutic Devices
To view Paxman’s complete acquisitions history, request access »

Paxman ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Paxman’s complete esg history, request access »

Paxman Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Dignitana Lund, Sweden 1996

Paxman FAQs

  • When was Paxman founded?

    Paxman was founded in 1996.

  • Where is Paxman headquartered?

    Paxman is headquartered in Karlshamn, Sweden.

  • What is the size of Paxman?

    Paxman has 151 total employees.

  • What industry is Paxman in?

    Paxman’s primary industry is Medical Supplies.

  • Is Paxman a private or public company?

    Paxman is a Public company.

  • What is Paxman’s stock symbol?

    The ticker symbol for Paxman is PAX.

  • What is the current stock price of Paxman?

    As of 13-Nov-2026 the stock price of Paxman is $6.73.

  • What is the current market cap of Paxman?

    The current market capitalization of Paxman is $157M.

  • What is Paxman’s current revenue?

    The trailing twelve month revenue for Paxman is $39.1M.

  • What is Paxman’s annual earnings per share (EPS)?

    Paxman’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process